Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GELESIS HOLDINGS, INC.GLS · Entity 109516 | Director | May 06, 2022 | May 09, 2022 |
| Inogen IncINGN · Entity 2083 | EVP, Finance, & CFO | December 01, 2021 | December 03, 2021 |
| Pear Therapeutics, Inc.PEAR · Entity 114512 | Director | February 15, 2023 | February 17, 2023 |
| Sight Sciences, Inc.SGHT · Entity 5537 | Chief Operating Officer | October 02, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GELESIS HOLDINGS, INC.
Report date May 06, 2022 · Filed May 09, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 51,095 |
Reported balance
After 2022-05-06 transaction · row 1
1 source rowRow 1 · 2022-05-06 · Grant · Acquired 51,095 · Balance 51,095 F1: Represents a grant of restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement. F2: These RSUs vest in full on March 1, 2023, subject to the reporting person's continued service at such time. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement.
F2: These RSUs vest in full on March 1, 2023, subject to the reporting person's continued service at such time.
Inogen Inc
Report date December 01, 2021 · Filed December 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,902 |
Last balance in matching sequence
After 2021-12-01 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2021-12-01 · Exercise / conversion · Acquired 546 · Balance 34,392 F1: Shares beneficially owned are 30,155 shares more than the previously filed Form 4s due to an error reporting the shares owned on December 15, 2020. An amendment to the original Form 4 has been filed to correct the error. Row 2 · 2021-12-01 · Tax withholding · Disposed 490 · Balance 33,902 F2: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2021. F1: Shares beneficially owned are 30,155 shares more than the previously filed Form 4s due to an error reporting the shares owned on December 15, 2020. An amendment to the original Form 4 has been filed to correct the error. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 4,915 |
Reported balance
After 2021-12-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-12-01 · Exercise / conversion · Disposed 546 · Balance 4,915 F3: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares beneficially owned are 30,155 shares more than the previously filed Form 4s due to an error reporting the shares owned on December 15, 2020. An amendment to the original Form 4 has been filed to correct the error.
F2: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2021.
F3: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F4: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date.
Pear Therapeutics, Inc.
Report date February 15, 2023 · Filed February 17, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 71,428 |
Reported balance
After 2023-02-15 transaction · row 1
1 source rowRow 1 · 2023-02-15 · Grant · Acquired 71,428 · Balance 71,428 |
Sight Sciences, Inc.
Report date October 02, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 639,449 |
Reported balance
After 2026-10-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-02 · Sale · Disposed 25,260 · Balance 639,449 F1: Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). F2: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.68 to $9.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: Includes (i) 214,450 shares of Common Stock, and (ii) 424,999 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
F2: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.68 to $9.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: Includes (i) 214,450 shares of Common Stock, and (ii) 424,999 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2020 Filed Sep 2, 2020 23:11 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 102 | $28.94 | $2,951.88 |
DisclosureSEC source: 0001209191-20-049260 · doc4.xml · nonDerivative · entry 3 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,679 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2020. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 23:11 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 125 | $28.94 | $3,617.50 |
DisclosureSEC source: 0001209191-20-049260 · doc4.xml · nonDerivative · entry 2 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,781 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2020. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 23:11 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 252 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049260 · doc4.xml · nonDerivative · entry 1 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,906 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 22:25 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034203 · doc4.xml · derivative · entry 5 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,263 Underlying: Common Stock · 253 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the Reporting Person continuing to be a service provider through each such vesting date. F3 · derivative.expiration_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the Reporting Person continuing to be a service provider through each such vesting date. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 22:25 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 116 | $38.55 | $4,471.80 |
DisclosureSEC source: 0001209191-20-034203 · doc4.xml · nonDerivative · entry 4 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,654 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2020. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 22:25 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 102 | $38.55 | $3,932.10 |
DisclosureSEC source: 0001209191-20-034203 · doc4.xml · nonDerivative · entry 3 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,770 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2020. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 22:25 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 126 | $38.55 | $4,857.30 |
DisclosureSEC source: 0001209191-20-034203 · doc4.xml · nonDerivative · entry 2 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,872 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2020. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 22:25 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034203 · doc4.xml · nonDerivative · entry 1 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,998 Read SEC document |
| March 01, 2020 Filed Mar 4, 2020 01:42 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-015816 · doc4.xml · derivative · entry 5 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,516 Underlying: Common Stock · 253 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date. F3 · derivative.expiration_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date. Read SEC document |
| March 01, 2020 Filed Mar 4, 2020 01:42 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 523 | $45.78 | $23,942.94 |
DisclosureSEC source: 0001209191-20-015816 · doc4.xml · nonDerivative · entry 4 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,745 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2020. Read SEC document |
| March 01, 2020 Filed Mar 4, 2020 01:42 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 115 | $45.78 | $5,264.70 |
DisclosureSEC source: 0001209191-20-015816 · doc4.xml · nonDerivative · entry 3 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,268 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2020. Read SEC document |
| March 01, 2020 Filed Mar 4, 2020 01:42 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 142 | $45.78 | $6,500.76 |
DisclosureSEC source: 0001209191-20-015816 · doc4.xml · nonDerivative · entry 2 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,383 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2020. Read SEC document |
| March 01, 2020 Filed Mar 4, 2020 01:42 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-015816 · doc4.xml · nonDerivative · entry 1 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,525 Read SEC document |
| February 28, 2020 Filed May 21, 2020 22:26 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Unit · Derivative | 8,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-031438 · doc4.xml · derivative · entry 1 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,737 Underlying: Common Stock · 8,737 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F2 · derivative.expiration_date: 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| December 01, 2019 Filed Dec 4, 2019 02:45 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 252 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-058929 · doc4.xml · derivative · entry 4 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,769 Underlying: Common Stock · 252 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date. F3 · derivative.expiration_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date. Read SEC document |
| December 01, 2019 Filed Dec 4, 2019 02:45 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 102 | $73.61 | $7,508.22 |
DisclosureSEC source: 0001209191-19-058929 · doc4.xml · nonDerivative · entry 3 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,272 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2019. Read SEC document |
| December 01, 2019 Filed Dec 4, 2019 02:45 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 125 | $73.61 | $9,201.25 |
DisclosureSEC source: 0001209191-19-058929 · doc4.xml · nonDerivative · entry 2 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,374 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2019. Read SEC document |
| December 01, 2019 Filed Dec 4, 2019 02:45 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 252 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-058929 · doc4.xml · nonDerivative · entry 1 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,499 Read SEC document |
| September 01, 2019 Filed Sep 5, 2019 00:46 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-048397 · doc4.xml · derivative · entry 4 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,021 Underlying: Common Stock · 253 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date. F3 · derivative.expiration_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date. Read SEC document |
| September 01, 2019 Filed Sep 5, 2019 00:46 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 103 | $46.37 | $4,776.11 |
DisclosureSEC source: 0001209191-19-048397 · doc4.xml · nonDerivative · entry 3 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,247 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2019. Read SEC document |
| September 01, 2019 Filed Sep 5, 2019 00:46 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 127 | $46.37 | $5,888.99 |
DisclosureSEC source: 0001209191-19-048397 · doc4.xml · nonDerivative · entry 2 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,350 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2019. Read SEC document |
| September 01, 2019 Filed Sep 5, 2019 00:46 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-048397 · doc4.xml · nonDerivative · entry 1 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,477 Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 22:18 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,315 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-19-047564 · doc4.xml · derivative · entry 4 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,702 Underlying: Common Stock · 2,315 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is April 1, 2014. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 22:18 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 1,685 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001209191-19-047564 · doc4.xml · derivative · entry 3 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,685 shares Expires 2021-10-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is August 1, 2011. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 22:18 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,315 | $16.62 | $38,475.30 |
DisclosureSEC source: 0001209191-19-047564 · doc4.xml · nonDerivative · entry 2 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 22:18 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,685 | $0.75 | $1,263.75 |
DisclosureSEC source: 0001209191-19-047564 · doc4.xml · nonDerivative · entry 1 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2019 Filed Jun 5, 2019 01:05 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-034600 · doc4.xml · derivative · entry 4 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,274 Underlying: Common Stock · 253 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date. F3 · derivative.expiration_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date. Read SEC document |
| June 01, 2019 Filed Jun 5, 2019 01:05 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 102 | $64.47 | $6,575.94 |
DisclosureSEC source: 0001209191-19-034600 · doc4.xml · nonDerivative · entry 3 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,224 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2019. Read SEC document |
| June 01, 2019 Filed Jun 5, 2019 01:05 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 126 | $64.47 | $8,123.22 |
DisclosureSEC source: 0001209191-19-034600 · doc4.xml · nonDerivative · entry 2 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,326 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2019. Read SEC document |
| June 01, 2019 Filed Jun 5, 2019 01:05 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-034600 · doc4.xml · nonDerivative · entry 1 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,452 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:20 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unis · Derivative | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016176 · doc4.xml · derivative · entry 9 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,527 Underlying: Common Stock · 253 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F7 · derivative.exercise_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date. F7 · derivative.expiration_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:20 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 284 | $106.97 | $30,379.48 |
DisclosureSEC source: 0001209191-19-016176 · doc4.xml · nonDerivative · entry 8 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,199 F5 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:20 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 88 | $106.97 | $9,413.36 |
DisclosureSEC source: 0001209191-19-016176 · doc4.xml · nonDerivative · entry 7 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,483 F5 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:20 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016176 · doc4.xml · nonDerivative · entry 6 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,571 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:20 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 490 | $106.97 | $52,415.30 |
DisclosureSEC source: 0001209191-19-016176 · doc4.xml · nonDerivative · entry 5 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,318 F3 · shares: The reported shares were withheld in a net issuance to cover the Reporting Person's tax withholding liability in connection with a portion of a performance-based restricted stock award that was earned and vested on March 1, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:20 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 1,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016176 · doc4.xml · nonDerivative · entry 4 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,808 F4 · shares: The reported securities represent shares earned and vested on March 1, 2019 based on achievement of the financial performance conditions for the 2018 fiscal year that were approved as part of the 2018 performance-based restricted stock award granted on March 2, 2018. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:20 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 466 | $106.97 | $49,848.02 |
DisclosureSEC source: 0001209191-19-016176 · doc4.xml · nonDerivative · entry 3 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,391 F3 · shares: The reported shares were withheld in a net issuance to cover the Reporting Person's tax withholding liability in connection with a portion of a performance-based restricted stock award that was earned and vested on March 1, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:20 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 1,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016176 · doc4.xml · nonDerivative · entry 2 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,857 F2 · shares: The reported securities represent shares earned and vested on March 1, 2019 based on achievement of the financial performance conditions for the 2018 fiscal year that were approved as part of the 2017 performance-based restricted stock award granted on August 8, 2017. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:20 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 3,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016176 · doc4.xml · nonDerivative · entry 1 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,510 F1 · shares: The reported securities represent shares of restricted stock, 25% of which shall vest on March 1, 2020, and 1/16th of which shall vest every three months thereafter on the 1st day of the month, subject in each case to the reporting person remaining a service provider through each such applicable vesting date. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 19:25 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 19,000 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-18-061185 · doc4.xml · derivative · entry 2 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,845 Underlying: Common Stock · 19,000 shares Expires 2023-10-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is October 1, 2013. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 19:25 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 19,000 | $8.37 | $159,030.00 |
DisclosureSEC source: 0001209191-18-061185 · doc4.xml · nonDerivative · entry 1 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2018 Filed Dec 3, 2018 22:49 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Units · Derivative | 252 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-060648 · doc4.xml · derivative · entry 3 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,780 Underlying: Common Stock · 252 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date. F3 · derivative.expiration_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date. Read SEC document |
| December 01, 2018 Filed Dec 3, 2018 22:49 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 125 | $147.36 | $18,420.00 |
DisclosureSEC source: 0001209191-18-060648 · doc4.xml · nonDerivative · entry 2 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,771 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2018. Read SEC document |
| December 01, 2018 Filed Dec 3, 2018 22:49 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 252 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-060648 · doc4.xml · nonDerivative · entry 1 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2018 Filed Sep 5, 2018 20:26 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Units · Derivative | 1,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-049562 · doc4.xml · derivative · entry 3 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,032 Underlying: Common Stock · 1,011 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date. F3 · derivative.expiration_date: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date. Read SEC document |
| September 01, 2018 Filed Sep 5, 2018 20:26 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 528 | $264.91 | $139,872.48 |
DisclosureSEC source: 0001209191-18-049562 · doc4.xml · nonDerivative · entry 2 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,644 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2018. Read SEC document |
| September 01, 2018 Filed Sep 5, 2018 20:26 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-049562 · doc4.xml · nonDerivative · entry 1 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:08 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001209191-18-037446 · doc4.xml · derivative · entry 6 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2019-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is February 10, 2009. This option is fully vested as of February 10, 2013. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:08 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 623 | $182.40 | $113,634.02 |
DisclosureSEC source: 0001209191-18-037446 · doc4.xml · nonDerivative · entry 5 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,161 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F5 · price: Represents the weighted average share price of an aggregate total of 623 shares sold in the price range of $182.00 to $182.46 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:08 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,220 | $181.40 | $221,304.58 |
DisclosureSEC source: 0001209191-18-037446 · doc4.xml · nonDerivative · entry 4 Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,784 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F4 · price: Represents the weighted average share price of an aggregate total of 1,220 shares sold in the price range of $181.00 to $181.51 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.